Alcohol use disorders (AUD) are prevalent and often go untreated. Patients are commonly screened for AUD in primary care, but existing treatment programs are failing to meet demand. Digital therapeutics include novel...
The Evidence-Based Practice Attitudes Scale (EBPAS) is widely used in implementation research, but it has not been adapted and validated for use among general education teachers, who are most likely to deliver evidence...
COVID-19 dramatically limited the scale and scope of local health department (LHD) work, redirecting resources to the response. However, the need for essential public health services—including substance use prevention—was not...
Opioid overdose remains a public health crisis in diverse communities. Between 2019 and 2020, there was an almost 40% increase in drug fatalities primarily due to opioid analogues of both stimulants and opioids. Medications for...
In the context of the current U.S. injection drug use epidemic, targeted public health harm reduction strategies have traditionally focused on overdose prevention and reducing transmission of blood-borne viral...
In response to the rising efficacy of the illicit opioid drug supply and often observed delays in access to follow-up therapy, emergency departments (EDs) occasionally utilize a high-dose buprenorphine induction method for the treatment of...
Importance: Emergency departments (EDs) sporadically use a high-dose buprenorphine induction strategy for the treatment of opioid use disorder (OUD) in response to the increasing potency of the illicit opioid drug supply and...
Background: Family caregivers contribute to engagement in treatment and adherence, reduced substance misuse and relapse, and increased well-being of recipients with substance use disorder. However, providing care has also been...
The Addiction Technology Transfer Center (ATTC) Network, the Center for Excellence on Protected Health Information (CoE-PHI), the National Consortium of Telehealth Resource Centers, and the Center for the Application of Substance Abuse...
It is recognised that smoking and use of tobacco products among lesbian, gay, bisexual, transgender and queer (LGBTQ) young adults is higher compared to their heterosexual and cisgender peers.
Although it is believed that within the LGBTQ...
Opioid use disorder is a chronic, relapsing disease and a global health burden. Treatment for OUD tends to involve a combination of medication and behavioural intervention. It is recognised that buprenorphine can alleviate opioid withdrawal...
Recent studies carried out by researchers from Vanderbilt University and Johns Hopkins University have examined characteristics linked with the heightened risk NAS.
The researchers found that boys are more likely to receive a diagnosis of...
Opioid Use Disorder (OUD), and the associated risk of overdose and death, is becoming one of the most prevalent threats to health and social wellbeing in the United States. Medication, such as buprenorphine, is the gold standard treatment...
A webinar on opioid use disorder by Dr. Dennis McCarty is now available through the Addiction Technology Transfer Centre (ATTC) website.
The hour long webinar took place in April 2018 and discusses treatment and prevention. The webinar...
